A.C. & C 8MG TAB

Main information

  • Trade name:
  • A.C. & C 8MG TAB TABLET
  • Dosage:
  • 8MG; 375MG; 15MG
  • Pharmaceutical form:
  • TABLET
  • Composition:
  • CODEINE PHOSPHATE 8MG; ACETYLSALICYLIC ACID 375MG; CAFFEINE 15MG
  • Administration route:
  • ORAL
  • Units in package:
  • 100
  • Prescription type:
  • Narcotic (CDSA I)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • A.C. & C 8MG TAB TABLET
    Canada
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • OPIATE AGONISTS
  • Product summary:
  • Active ingredient group (AIG) number: 0301235001; AHFS: 28:08.08

Other information

Status

  • Source:
  • Health Canada
  • Authorization status:
  • APPROVED
  • Authorization number:
  • 00180041
  • Authorization date:
  • 19-11-2001
  • Last update:
  • 29-11-2018

3-8-2012

Danish Pharmacovigilance Update, 21 June 2012

Danish Pharmacovigilance Update, 21 June 2012

Among the topics covered in this issue of Danish Pharmacovigilance Update are: Decrease in the number of intoxications and suicide attempts using drugs containing acetylsalicylic acid or paracetamol.

Danish Medicines Agency

29-10-2018

Clopidogrel/Acetylsalicylic acid Zentiva (Sanofi-Aventis groupe)

Clopidogrel/Acetylsalicylic acid Zentiva (Sanofi-Aventis groupe)

Clopidogrel/Acetylsalicylic acid Zentiva (Active substance: clopidogrel / acetylsalicylic acid) - Centralised - 2-Monthly update - Commission Decision (2018)7249 of Mon, 29 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1144/WS1433/0051

Europe -DG Health and Food Safety

29-10-2018

DuoPlavin (Sanofi Clir SNC)

DuoPlavin (Sanofi Clir SNC)

DuoPlavin (Active substance: clopidogrel / acetylsalicylic acid) - Centralised - 2-Monthly update - Commission Decision (2018)7255 of Mon, 29 Oct 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1143/WS/1433/0050

Europe -DG Health and Food Safety